MiCA Stablecoin Regulation Summary 2026 — Title III ART + Title IV EMT

The two-track regime

MiCA’s stablecoin regulation is a two-track regime. The split between Title III and Title IV governs which regulatory framework applies, which issuers are eligible, what reserve requirements apply, and which supervisor relationship operates.

The split turns on a single question: does the token reference a single official currency, or does it reference something else?

Single official currency reference → EMT (Title IV). Tokens designed to maintain stable value by referencing a single official currency — Euro, US Dollar, Pound Sterling, Yen, or any other single fiat currency. The classic single-currency stablecoin design.

Anything else → ART (Title III). Tokens that reference a basket of assets (multiple currencies, mixed asset baskets, commodities, or any combination). Algorithmic stablecoins that maintain stability through non-reserve mechanisms are typically out of MiCA scope entirely — Article 3(1)(7) explicitly excludes them from ART definition. Algorithmic stablecoins face material regulatory uncertainty under MiCA.

The line is sharp on paper but produces real operational consequences. Issuer eligibility differs sharply between regimes. Reserve requirements differ. Supervisor relationship differs. Customer rights differ. Designing a stablecoin product without confirming which regime applies is the most common stablecoin compliance error.

Title III — ART issuer authorisation

Title III governs asset-referenced tokens (ART) under Articles 16-47 of MiCA. Issuing an ART is a regulated activity in its own right — separate from CASP service provision, and closer in shape to a credit-institution authorisation than to a CASP file. An entity that wants both to issue an ART and to provide custody of it needs two authorisations.

Two authorisation routes. Title III sets out two pathways. Under Article 16, a non-credit-institution files a standalone ART issuer application with its home NCA — the dedicated ART track open to fintech and crypto-native projects. Under Article 17, a credit institution already authorised under the CRR issues ARTs by notification and white-paper approval rather than a separate Title III authorisation; the existing banking licence carries the substantive prudential credit. In practice, large traditional-finance issuers take the Article 17 route — Société Générale-FORGE’s EUR CoinVertible was issued via the credit-institution route rather than a standalone authorisation.

Statutory clock. Article 21 gives the NCA three months from a complete file to decide. Realistic end-to-end timing for a standalone Article 16 application runs longer — 9-12 months once the reserve build and white-paper cycles are factored in.

Capital requirements. Article 35 sets own funds at the higher of EUR 350,000 or 2% of the average amount of the asset reserve. For an ART with EUR 100 million outstanding, the 2% floor of EUR 2 million is the live constraint. The capital must be CET1 quality, and unlike the CASP own-funds rule, it cannot be replaced by an insurance policy. Article 43-designated issuers face enhanced capital under the significant-ART framework.

Reserve requirements. Articles 36-38 require a full reserve of assets at least equal to the value of outstanding ARTs. The reserve is segregated and bankruptcy-remote from the issuer. It has to be composed of liquid high-credit-quality assets subject to concentration limits per the EBA RTS, and custodied by an independent credit institution or qualifying CASP — self-custody is not permitted. The custody and operational build is typically the longest workstream. See MiCA stablecoin reserves for the composition mechanics in detail.

Redemption rights. Article 39 gives every ART holder a permanent right of redemption at fair-market value or in the reference assets, with procedures, timelines, and fees disclosed in the white paper. Redemption must be operationally feasible from Day 1 — verification first, then asset disposal and settlement. For a basket-backed ART, the redemption flow is materially more complex than for a single-currency token.

White paper and ongoing obligations. Article 19 requires an NCA-approved white paper before the ART is offered to the public or admitted to trading, with content covering reserve composition, the stabilisation mechanism, redemption mechanics, and risk factors. Articles 27-30 add ongoing transparency, customer-disclosure, and supervisor-reporting obligations, including periodic publication of reserve composition. The dedicated walk-through is MiCA ART issuer authorisation — Title III in practice.

Title IV — EMT issuer authorisation

Title IV governs e-money tokens (EMT) under Articles 48-58 of MiCA. It is narrower in scope than Title III but heavier in several substantive areas, because MiCA treats an EMT, in substance, as electronic money and layers it onto the existing EMD2 framework.

Issuer eligibility. Under Article 48, EMT issuance is limited to credit institutions and electronic money institutions (EMIs). The issuer base is intentionally narrower than ART. There is no separate “EMT issuer” licence — the issuer has to be one of those two regulated entity types. A pure-tech stablecoin project that holds neither must either obtain EMI authorisation or partner with an authorised issuer.

Three authorisation routes. A CRR-authorised credit institution issues EMTs by notification — no separate Title IV authorisation. An existing EMI authorised under EMD2 (Directive 2009/110/EC) does the same; several Lithuanian and Maltese EMIs have entered EMT issuance this way. A non-credit-institution without an EMI authorisation must obtain one in parallel with the EMT file. For a clean first-time application, the end-to-end timeline runs 9-12 months — the EMI authorisation (typically 6-9 months) sits on top of the three-month EMT notification clock.

Reserve requirements. EMT reserves must be 100% backed and held in commercial-bank or central-bank money — not in money-market fund units, commercial paper, or government securities. Reserves are segregated, bankruptcy-remote, held with an independent custodian, and reconciled daily against outstanding EMTs. Several pre-MiCA issuers used MMFs; under Title IV that structure is not permitted. The reserve composition rule is covered in MiCA stablecoin reserves.

Redemption rights. Article 49 requires par-value redemption at all times — a 1:1 exchange with the reference currency that is unconditional and, for retail-sized redemptions, free. The issuer may not charge a fee for redemptions below EUR 100,000 per holder per one-month period, and settles within the working day. The at-par redemption obligation is the substantive heart of Title IV and the operating constraint that makes EMT economics demanding.

AMLR overlay. EMT issuers are obliged entities under the AML Regulation (Regulation (EU) 2024/1624), applying from 10 July 2027. Customer due diligence and ongoing monitoring, plus the reporting obligations that follow, sit on top of the Title IV substantive rules — a planning horizon EMT issuers operating in 2026 need on the roadmap. The dedicated walk-through is MiCA EMT issuer authorisation — Title IV in practice.

Designation. Article 56 provides for EMT significance designation by EBA where the EMT exceeds specified thresholds — issuance volume above EUR 5 billion, ten million active EU users, cross-border use across at least seven member states, or payment-system relevance. Designated EMT issuers face enhanced supervision, additional reporting, and stress-testing.

Reserve requirements — Articles 36 and 54

Both regimes require a reserve that covers the issuer’s liability to holders, but the composition rules diverge in operationally important ways.

ART reserves (Article 36). Principle-based. The reserve must be composed and managed to hedge the market and exchange-rate risks arising from the reference basket. It has to stay at least equal to the value of tokens in circulation and be managed prudently. The issuer must adopt and publish a clear reserve-management policy describing the stabilisation mechanism, listing the reference assets, and assessing the reserve’s risks. Reserve assets are segregated and held with a qualifying third-party custodian — a CASP, credit institution, or investment firm.

EMT reserves (Article 54). Partially prescribed. At least 30% of the funds received must sit in segregated credit-institution deposit accounts; the remainder goes into highly liquid financial instruments with minimal market, credit, and concentration risk. The non-deposit portion must be denominated in the same official currency the EMT references — a euro-pegged EMT cannot back its reserve with dollar-denominated instruments, even where that would improve portfolio risk on traditional measures. The 30% floor is a structural prudence requirement, not an investment-strategy choice.

The interest prohibition. Neither ART nor EMT issuers may grant interest on tokens held by holders, directly or through affiliated arrangements. The prohibition is structural, not a disclosure rule — “earn programmes” and yield-bearing pools, along with reward-token mechanics designed to track holding period, are all incompatible with MiCA. Marketing copy promising “yield on stablecoin balances” triggers supervisory enforcement even where the technical mechanics avoid a literal interest payment.

Cited expert

In the EU, MiCA introduces stringent requirements for stablecoin issuers, including prudential and governance rules, as well as obligations regarding the composition and management of stablecoins reserves.

Comparing ART and EMT in practice

The regimes look similar in structural outline but differ in important operational details.

Issuer eligibility. ART has the broader issuer base — non-credit-institution applicants can pursue Article 16 authorisation. EMT is limited to credit institutions and EMIs only. The eligibility difference is the single most important consideration for stablecoin project structuring.

Authorisation route complexity. ART Article 16 authorisation is a dedicated MiCA process designed for crypto-asset issuers. EMT operates through E-Money Directive authorisation plus MiCA Title IV overlay. EMT is operationally simpler for entities that already hold EMI or credit-institution authorisation; ART is operationally simpler for new entrants.

Reserve composition flexibility. ART Article 36 allows broader reserve composition, from multi-asset baskets to commodity exposure and other diversified holdings. EMT Article 54 reserve is narrower — deposits and high-quality liquid assets aligned with E-Money standards. The flexibility difference matters for product design.

Redemption rules. ART Article 39 provides par-value redemption rights with defined procedures. EMT Article 49 provides par-value redemption at all times without restriction. The redemption framework is materially more strict under EMT.

Customer perception. EMT-style single-currency stablecoins (USDC, EURT-equivalents) are more familiar to retail customers and easier to integrate into existing payment-system relationships. ART-style multi-asset stablecoins serve different use cases — typically institutional, treasury management, or specialised payments.

Significance threshold dynamics. Both regimes have significance designation but at different threshold levels and with different practical consequences. EMT designation focuses on payment-system role; ART designation focuses on broader market impact.

Choosing the issuer licence — EMI vs MiCA ART route

For a stablecoin issuer, the licence is not a preference; the token category decides it. Get the category right and the licence path is one specific regime. Get it wrong and the project scopes the wrong rulebook and the wrong issuer type, then builds the wrong corporate setup from day one.

EMT issuer route — EMI authorisation under EMD2. A token referencing one official currency is an EMT, and the issuer must be a credit institution or an authorised EMI under EMD2. The EMI is the standard path for a non-bank issuer: minimum initial capital EUR 350,000, ongoing own funds that scale with e-money in issuance, EMD2 safeguarding of received funds, and redemption at par at any time. It is a real regulated-financial-institution build-out, not a crypto-light setup.

ART issuer route — MiCA Title III authorisation. A token referencing anything else (multiple currencies, a commodity, a basket, other crypto-assets) is an ART, authorised under the bespoke Title III regime with its own capital, reserve, governance, and conduct obligations, or issued by a credit institution.

A single-currency stablecoin routed through the ART regime fails twice: the regulator points out that EMT rules apply, then the team rebuilds the plan around the EMI authorisation that should have been the starting point. The reverse is also true — a basket-backed token taken through EMI authorisation will not pass. Neither route is a CASP authorisation, which covers crypto-asset services, not token issuance; a firm doing both runs two regulated activities in parallel. The full comparison is in stablecoin issuer licence — EMI vs MiCA ART issuer.

Designation framework

Both Title III and Title IV provide for significance designation by EBA where the token exceeds specified thresholds. The frameworks parallel but are not identical.

ART significance — Article 43. EBA can designate an ART under Article 43 where the average issuance volume exceeds EUR 5 bn, average daily transaction value exceeds EUR 500 m, or other quantitative or qualitative criteria suggest material market impact. Designation triggers enhanced supervision including direct EBA engagement, higher capital requirements, and enhanced ongoing reporting.

EMT significance — Article 56. EBA can designate an EMT under Article 56 where issuance volume, holders, daily transactions, or payment-system role exceed specified thresholds. Designated EMTs face enhanced supervision plus specific obligations related to payment-system role and stability.

Operational consequences of designation. Both significance categories produce enhanced reporting obligations, EBA direct supervisor engagement, higher capital and reserve requirements, enhanced operational resilience requirements, and stress-testing obligations. The enhanced framework is materially more demanding than baseline ART or EMT obligations.

Designation review. Both regimes provide for annual EBA designation review. Tokens that cross thresholds face designation; tokens that fall below sustained thresholds may be de-designated. The designation status is not necessarily permanent.

Significant issuers — the additional rules

Designation is not a label; it is a different regulatory profile, modelled on the banking distinction between baseline supervision and enhanced supervision for systemically relevant institutions. The largest ART issuers carry the heaviest version of it.

Enhanced capital. A designated ART issuer’s own funds rise to the higher of EUR 350,000 or 3% of reserve-asset value — up from the 2% baseline in Article 35. The one-percentage-point difference is material at scale: a EUR 10 billion reserve produces EUR 200 million of required capital at 2% and EUR 300 million at 3%, a EUR 100 million differential that cannot be deployed in revenue-generating activity.

Enhanced governance. Designated issuers must run board independence, enhanced fit-and-proper testing for senior management, an independent risk function, internal audit reporting to the audit committee, and periodic reserve stress-testing whose results feed supervisory engagement.

Recovery and resolution. Designated issuers maintain recovery and resolution arrangements modelled on the bank framework under BRRD — a pre-positioned recovery plan, identified critical functions (ART redemption, reserve management, customer service), operational-continuity arrangements, and resolution-authority engagement. Building a genuine framework typically takes 12-18 months.

College supervision. Supervision shifts to an EBA-led college that includes the home NCA, host NCAs, ESMA, and the ECB. The home NCA retains day-to-day operational supervision under college coordination, but enhanced measures run through the college — quarterly meetings and more granular reporting, plus joint on-site inspections.

Voluntary designation. An issuer may request designation before EBA assessment requires it. The rationale is institutional signalling and supervisory-engagement quality, together with cross-border supervisory clarity; the trade-off is accepting the higher cost and operational complexity earlier than the thresholds would force it. The full treatment is in designated ART issuer additional rules.

White-paper requirements across the three Titles

“MiCA white paper” sounds like one document. It is three legally distinct regimes triggered by token classification, and picking the wrong one is where most issuance projects stumble.

Title III — ART. Prior authorisation by the home NCA before any public offer or admission to trading. The white paper content under Annex II is the heaviest of the three — reserve composition, the stabilisation mechanism, redemption rights, capital, prudential reporting. A Title III file reads closer to a full credit-institution authorisation than a token disclosure.

Title IV — EMT. The white paper is notified to the home authority, but the gating constraint is the issuer-status requirement: only a credit institution or an EMI can issue. The disclosure focuses on the currency reference, reserve arrangements, and at-par redemption.

Title II — other crypto-assets. The default regime for utility and governance tokens, and the lighter one — no reserves or redemption, and no issuer capital floor. The issuer notifies the home NCA at least 20 working days before the public offer; the NCA receives and may object during the window but does not approve the content. Marketing that claims an “NCA-approved white paper” is misleading. Most Title II enforcement through 2026 has targeted the Article 7 marketing rule rather than white-paper content.

Exemptions (Title II). The Article 4(2) exemption set is a list, not a hierarchy — an offer must qualify under at least one limb: offers below EUR 1,000,000 over a 12-month period EU-wide (aggregated, not per member state), offers to fewer than 150 persons per member state, qualified-investor-only offers, mining and validation rewards, and free distributions where no personal data is exchanged. A single-currency or basket token is an EMT or ART by definition and cannot use the Title II route at all.

Format. From 23 December 2025, white papers under all three Titles must be filed in inline XBRL (iXBRL/XHTML) with a valid LEI, per Commission Implementing Regulation (EU) 2024/2984. Prospectus-style PDFs adapted from securities practice are rejected on format alone. The two dedicated walk-throughs are MiCA white paper requirements 2026 and MiCA token sale rules 2026.

NFT exemption — when it applies

The headline rule is simple: unique and non-fungible crypto-assets sit outside MiCA. The operating reality is narrower. ESMA’s guidelines (ESMA75-453128700-1323, March 2025) and 2025-2026 supervisory practice apply a substance-over-form test, and the mere attribution of a unique identifier (an ERC-721 token ID) is not by itself enough to qualify an asset as unique and non-fungible.

The test asks whether the asset’s value primarily stems from its unique characteristics and individual utility, or from interchangeability with siblings in a series. On that basis:

• Out of scope — genuine 1-of-1 art NFTs and individual tokenised real-world assets where each token represents a distinct underlying.
• In scope despite NFT branding — large semi-identical collections (the 10,000-piece PFP series, where pieces share substantially identical rights), fractionalised NFTs (the fractions are interchangeable), and NFT-wrapped financial instruments.

A separate point catches issuers: failing the MiCA NFT exemption is not the same as being a financial instrument under MiFID II. A unique tokenised bond can be outside MiCA scope yet inside MiFID II. Two parallel analyses are required, and an issuer relying on the exemption should keep a documented substance memo for supervisory enquiry. The dedicated treatment is when NFTs are inside MiCA scope.

US contrast — the GENIUS Act (non-EU)

This section is the deliberate non-EU comparison. The United States does not apply MiCA; its federal stablecoin framework is the GENIUS Act of 2025 (Guiding and Establishing National Innovation for US Stablecoins Act), which sits alongside the Bank Secrecy Act AML regime and a state money-transmitter overlay.

The structural parallels with MiCA’s EMT regime are close. The GENIUS Act covers single-currency, US-dollar-denominated stablecoins; requires full 1:1 reserve backing in US-dollar cash, deposits at insured depository institutions, and short-term US Treasury securities; mandates segregation and par-value redemption; and runs an authorised-issuer framework. The differences are the supervisory architecture and the threshold mechanics:

• Federal-state split. Issuers authorise through a federal charter (OCC supervision with Federal Reserve coordination), a state charter (state banking department with federal coordination above thresholds), or an insured-depository-institution subsidiary. MiCA, by contrast, runs EU member-state authorisation with an EU passport.
• USD 10bn threshold. Outstanding issuance above USD 10 billion triggers enhanced federal oversight — mandatory federal coordination and additional capital, alongside enhanced operational-resilience and reporting requirements. The mechanism parallels MiCA’s Article 56 significance designation.
• Securities-law residue. Standard reserve-backed stablecoins sit outside SEC securities regulation under the framework, but yield-bearing designs typically trigger Howey-test analysis and SEC engagement — mirroring the EU interest prohibition from the opposite direction.

For a global issuer, dual authorisation under both the GENIUS Act and MiCA’s EMT regime is the operational reality rather than a choice between them. The dedicated treatment is SEC stablecoin regulation USA 2026 — the GENIUS Act.

UK contrast — the FCA/FSMA stablecoin regime (non-EU)

Post-Brexit, the UK sits outside MiCA and runs its own build. UK stablecoin regulation is the emerging framework for fiat-backed stablecoin issuance under FSMA 2000, administered by the HM Treasury consultation and the Financial Conduct Authority, and phasing in through 2026-2027. Fiat-backed, single-currency stablecoins are the initial focus; algorithmic designs aren’t in scope at this phase.

The structural map onto MiCA’s EMT regime is close — full 1:1 reserve backing, segregation that protects holders in insolvency, high-quality liquid reserve assets, par-value redemption, and an authorised-issuer framework. Issuers need FCA authorisation as a stablecoin issuer, or an existing UK financial-services authorisation (e-money, credit, or payment institution) with a stablecoin permission added. UK-incorporation and UK-resident senior management under the FCA’s SMF regime, together with a real UK operational build, are the substance bar — thin-substance files face refusal. Clean applications run 9-18 months.

The one feature MiCA doesn’t have is the systemic layer. Under FSMA 2023 amendments, the Bank of England oversees stablecoins that become systemic in the UK payment system — a dedicated systemic supervisor sitting on top of FCA primary supervision, with enhanced capital, operational-resilience, stress-testing, and recovery-and-resolution obligations. It parallels MiCA’s Article 43/56 significance designation but goes further: MiCA’s designation triggers enhanced EBA supervision, not a separate systemic regulator. And a UK authorisation carries no EU passport — a UK-issued stablecoin reaching EU customers still faces Title IV EMT classification and likely a separate EU authorisation. For a global issuer, UK plus MiCA is dual licensing, not a choice. The dedicated treatment is UK stablecoin regulation 2026 — the FCA/FSMA framework.

Singapore contrast — the MAS stablecoin framework (non-EU)

Singapore moved first among major Asia-Pacific jurisdictions. The Monetary Authority of Singapore finalised its stablecoin framework in August 2023 and operationalised it through 2024-2025 under Payment Services Act 2019 amendments and dedicated MAS notices. It covers single-currency-pegged stablecoins (SCS) pegged to the Singapore Dollar or any G10 currency — USD, EUR, GBP, JPY, AUD, CAD, CHF, SEK, NOK, NZD. Multi-currency baskets and commodity-backed tokens, along with algorithmic designs, fall outside the dedicated SCS regime.

The requirements track MiCA’s EMT regime — full 1:1 reserve backing, segregation through statutory trust or dedicated custody, MAS-approved low-risk reserve assets, custody with MAS-approved institutions, and par-value redemption. Two differences stand out. First, the timing: MAS is already operational, where MiCA’s EMT regime and the UK framework arrived later. Second, the concrete numbers MAS sets in Notice PSN03 — base capital of SGD 1m minimum or 50% of annual operating expenses (whichever is higher), daily reserve-adequacy verification, and par-value redemption within five business days of a request.

Issuers go through one of two routes: a standalone SCS issuer authorisation for new entrants, or a permission added to an existing MAS licence for banks and payment institutions. Either way the substance bar is banking-grade — Singapore incorporation and a MAS-approved CEO and head of compliance, backed by a real Singapore-based compliance, AML, and risk team. Clean files run 6-12 months. As with the UK, there’s no passport — MAS authorisation is Singapore national scope, so a global issuer servicing the EU still needs a separate EMT authorisation. The dedicated treatment is Singapore stablecoin regulation 2026 — the MAS framework.

The major EU stablecoin issuers in 2026

The EU stablecoin market in 2026 includes several authorised issuers across both regimes:

Circle (EMT pathway). Circle’s EUR-denominated and USD-denominated tokens operate through Circle Internet Financial Europe SAS — Circle’s French EMI subsidiary authorised by ACPR. The Circle structure is the prototypical Title IV EMT framework — a credit-institution-equivalent issuer with full reserve management and integrated supervisor engagement.

Several smaller EMT issuers. Various European bank-affiliated and EMI-affiliated issuers operating EUR-stablecoins under Title IV. The population is growing as more EMIs add stablecoin offerings under the MiCA framework.

ART issuers under Article 16. Smaller but emerging population of Article 16-authorised ART issuers — typically multi-currency or commodity-referenced tokens. The application pipeline is substantial as fintech projects navigate the Article 16 authorisation process.

Designations. As of 2026, EBA has designated several EMT issuers under Article 56. ART significance designations are pending as the broader ART issuer population matures.

Practical takeaways

MiCA stablecoin regulation produces a structured two-track framework. The right approach depends on the specific stablecoin design and the issuer’s existing authorisation status. Three principles for stablecoin projects:

Confirm ART vs EMT classification before product design. The split determines authorisation pathway, reserve framework, customer rights, and supervisor relationship. Designing without confirming classification produces serious regulatory exposure and rework.

Plan issuer authorisation pathway with realistic timeline. EMT pathway through existing EMI or credit-institution authorisation is faster for already-authorised entities (3-9 months for MiCA Title IV overlay). ART pathway through Article 16 dedicated authorisation runs 9-18 months. Stablecoin product launch timing must account for the authorisation timeline.

Build reserve management and operational infrastructure for significance designation. Successful stablecoin projects cross designation thresholds quickly. Building infrastructure for the enhanced significance framework from the start produces smoother regulatory operations than retrofitting after designation lands.

For corrections, updates, or counsel referrals on MiCA stablecoin regulation, email [email protected].